Novo Nordisk Logo

Novo Nordisk

đŸ‡©đŸ‡°
NOVO B
DK0062498333

Novo Nordisk is a leading global pharmaceutical company from Denmark, focusing on developing innovative therapies. Its primary areas of expertise are diabetes and obesity, while rare blood disorders and hormone-related conditions are also core business segments. The company is dedicated to improving patient health and quality of life worldwide through advanced medicines.

Next Quarterly Earnings

Wednesday, August 5, 2026
CW 32
Pre-Market
In 30 days

Stock Price

All Dates

Company Information

Name
Novo Nordisk
Ticker Symbol
NOVO B
ISIN
DK0062498333
Country
đŸ‡©đŸ‡°
Denmark
More Financial Information